Fate Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress
Go back to Fate Therapeutics Reports Fourth Quarter and Full Year 2018 Financial Results and Highlights Operational Progress| FATE THERAPEUTICS (NASDAQ: FATE) | Delayed: 2.16 +0.01 (0.47%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $2.15 | 52 Week High | $4.76 | |||
| Open | $2.10 | 52 Week Low | $1.46 | |||
| Day High | $2.32 | P/E | N/A | |||
| Day Low | $2.07 | EPS | $-1.91 | |||
| Volume | 7,846,087 | |||||
